MANIPALHOS · NSE
Manipal Health Enterprises Limited
₹702.2
+0.83% (+₹5.75)
Prev. close
₹696.45
Volume
11,61,682
Delivery %
58.8%
As of
20 Nov 2026
Price history
Analyst sentiment
Analysts lean bullish
1 analyst stance · last 90 days · one per analyst
Trackable
1 · 1 bull / 0 neutral / 0 bear
Long-Horizon
none in range
Commentary
none in range
Trackable = verdict-bearing calls · Long-Horizon = 1yr+ horizon, verdict pending · Commentary = context, not graded
Analyst opinions
| Call | Analyst | Instrument | Verdict | Actions |
|---|---|---|---|---|
| “Initiated coverage on Manipal Health with a 'Buy' rating and a target price of ₹1,000, indicating a 25.32% upside from i…” | HSBC AnalysisHSBC | Manipal Health | PENDING |
Market commentary · 2 · levels, conditionals, previews, macro & hedged views — context, not graded
| Call | Analyst | Instrument | Verdict | Actions |
|---|---|---|---|---|
| “Manipal Health Enterprises is trading at a premium valuation with limited margin of safety, as IPO proceeds are largely …” | Shivani NyatiSwastika Investmart Ltd. | Manipal Health Enterprises | — | |
| “Manipal Health Enterprises is set to become debt-free using IPO proceeds, a significant achievement in the healthcare se…” | Arun KejriwalKejriwal Research and Investment Services | Manipal Health Enterprises | — |
Fundamentals
About Manipal Health Enterprises Limited
Manipal Health Enterprises Limited operates hospitals in India. The company offers services, such as multi-specialty tertiary and quaternary care through its network of hospitals. Its services include accident and emergency care, cancer care, cardiology, organ transplants, obstetrics and gynaecology, neurology, nephrology, orthopaedics, proctology, rheumatology, and urology. The company also offers medical services, including robotic spine surgery, bariatric surgery, head and neck surgery, liver transplantation, dialysis, laparoscopic surgery, organ transplant, orthopaedic robotic surgery, spine care, and clinics for conditions like epilepsy, chronic pain, and diabetes. In addition, it offers home care, a woman's and childcare centre, an insurance helpdesk, and international patient services, diagnostic services, pharmacy sales, home healthcare, teleconsultations, e-pharmacy, and digital health solutions. Further, it delivers outpatient treatment, diagnostics, and advanced clinical care through its hospital network, and collaborates with foundations and NGOs to offer healharmathcare services to underserved populations. The company was formerly known as Manipal Health Enterprises Private Limited and changed its name to Manipal Health Enterprises Limited in December 2025. The company was founded in 1991 and is headquartered in Bengaluru, India.
Details
Sector
Healthcare
Industry
Medical Care Facilities
CEO
Mr. Dilip Jose Puthiyidathu
Headquarters
Bengaluru
Employees
24,240
Website
manipalhospitals.comExchange
View on NSE ↗Key stats
Market cap
₹87,761.96 Cr
P/E ratio (TTM)
137.9
Dividend yield
0.00%
EPS (TTM)
₹4.84
Shares float
14.05 Cr
EPS · quarter ended Jun 2026
₹1.76
Financial Performance
01 · Financials
02 · Earnings Per Share (EPS)
04 · Operating Efficiency (Growth Rates)
Balance-sheet-based · pre-FY23 not filed in verifiable form
05 · Capital Structure & Asset Utilization
Pre-FY23 not filed in verifiable form
Asset turnover needs a prior year of assets — omitted for the earliest available year.
06 · Asset Base Composition
Pre-FY23 not filed in verifiable form
07 · Debt Level & Coverage
Pre-FY23 not filed in verifiable form
08 · Profit & Loss
Annual
| Line item | FY24 | FY25 | FY26 |
|---|---|---|---|
| ₹6,079.39 Cr | ₹9,263.56 Cr | ₹10,935.62 Cr | |
EBITDA | ₹1,546.86 Cr | ₹2,455.03 Cr | ₹2,834.87 Cr |
| ₹594.32 Cr | ₹512.96 Cr | ₹654.93 Cr | |
Diluted EPS | ₹4.52 | ₹3.9 | ₹4.98 |
09 · Balance Sheet — as filed
Annual
| Line item | FY26 |
|---|---|
| ₹20,755.47 Cr | |
Inventories | ₹169.85 Cr |
Investments | ₹2,392.36 Cr |
Trade receivables | ₹929.76 Cr |
Cash and cash equivalents | ₹299.36 Cr |
Bank balances other than cash and cash equivalents | ₹23.86 Cr |
Loans | ₹4.07 Cr |
Other financial assets | ₹173.99 Cr |
Other current assets | ₹109.29 Cr |
Total | ₹4,102.54 Cr |
| ₹24,864.51 Cr | |
| ₹8,426.13 Cr | |
| ₹8,798.80 Cr | |
Borrowings | ₹9,948.80 Cr |
Lease liabilities | ₹2,230.41 Cr |
Other financial liabilities | ₹178.76 Cr |
Provisions | ₹63.17 Cr |
Deferred tax liabilities (net) | ₹282.21 Cr |
Total | ₹12,703.35 Cr |
Borrowings | ₹604.62 Cr |
Lease liabilities | ₹79.22 Cr |
total outstanding dues of micro enterprises and small enterprises | ₹61.21 Cr |
total outstanding dues of creditors other than micro enterprises and small enterprises | ₹1,403.35 Cr |
Other financial liabilities | ₹858.51 Cr |
Other current liabilities | ₹283.99 Cr |
Provisions | ₹70.88 Cr |
Current tax liabilities (net) | ₹58.00 L |
Total | ₹3,362.36 Cr |
Total equity and liabilities | ₹24,864.51 Cr |
The company’s own captions, order and figures from its annual reports. A dash means the company printed no figure on that line that year. Each year is read from the latest annual report that carries it and was checked against the headline total shown elsewhere on this page.
All years: consolidated statements.
10 · Cash Flow Statement — as filed
Annual
| Line item | FY25 | FY26 |
|---|---|---|
| ₹1,569.82 Cr | ₹2,078.44 Cr | |
| ₹-2,658.33 Cr | ₹-7,036.78 Cr | |
| ₹291.28 Cr | ₹299.36 Cr |
The company’s own captions, order and figures from its annual reports. A dash means the company printed no figure on that line that year. Each year is read from the latest annual report that carries it and was checked against the headline total shown elsewhere on this page.
All years: consolidated statements.
11 · Shareholding Pattern
NSE, quarterly
| Line item | Aug 26 |
|---|---|
| Promoter | 72.08% |
| Public | 27.92% |
| Employee trusts | 0.00% |
Source: NSE quarterly shareholding-pattern filings, collapsed to periods where the reported percentages held steady — a column spanning several quarters means no change was filed across them. No FII/DII sub-split available from this source — Public includes all non-promoter, non-employee-trust holders.
12 · Peer Comparison
Healthcare
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹4.25 L Cr | ₹1,769.9 | 38.8 | 5.09 | 13.7% | 0.06 | +11.9% | +3.7% |
| Divi's Laboratories Limited | ₹2.66 L Cr | ₹10,037.5 | 90.8 | 15.85 | 15.3% | 0.00 | +12.3% | +47.5% |
| Torrent Pharmaceuticals Limited | ₹1.79 L Cr | ₹4,738.5 | 79.4 | 21.31 | 25.8% | 1.79 | +21.5% | +32.5% |
| Laurus Labs Limited | ₹1.27 L Cr | ₹2,348 | 94.8 | 23.94 | 16.8% | 0.48 | +22.0% | +146.2% |
| Apollo Hospitals Enterprise Limited | ₹1.23 L Cr | ₹8,599.5 | 58.8 | 12.95 | 20.5% | 0.90 | +15.7% | +10.1% |
| Zydus Lifesciences Limited | ₹1.19 L Cr | ₹1,188.1 | 26.7 | 4.40 | 18.6% | 0.46 | +18.4% | +22.3% |
| Lenskart Solutions Limited | ₹1.16 L Cr | ₹689.7 | 181.4 | 13.30 | 5.6% | 0.35 | +35.4% | — |
| Dr. Reddy's Laboratories Limited | ₹1.14 L Cr | ₹1,374 | 40.6 | 3.02 | 11.4% | 0.21 | +3.2% | +14.5% |
| Cipla Limited | ₹1.13 L Cr | ₹1,402 | 38.9 | 3.27 | 11.3% | 0.02 | +2.1% | -6.7% |
| Mankind Pharma Limited | ₹1.03 L Cr | ₹2,475 | 45.9 | 6.31 | 11.7% | 0.39 | +17.0% | +3.1% |
| Aurobindo Pharma Limited | ₹98,101.93 Cr | ₹1,705 | 26.6 | 2.59 | 9.2% | 0.21 | +6.4% | +48.4% |
| Manipal Health Enterprises Limited | ₹87,761.96 Cr | ₹667.2 | 137.9 | 10.42 | 7.8% | 1.53 | +18.0% | — |
Ranked by market cap within Healthcare, same metrics as the Fundamentals screener. Click a column to sort.
Documents
IPO documents
Official documents linked from their sources — offer documents as filed with SEBI (sebi.gov.in), annual reports and earnings-call transcripts as published on BSE (bseindia.com) and NSE (nseindia.com). Links open the source's own hosting; nothing is re-hosted here.
Manipal Health Enterprises Completes Acquisition of Kinder Women’s Hospital for INR 130 Cr
Digital Health News · 3 days ago